| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
(2S,4R)-4-METHYLGLUTAMIC ACID
|
31137-74-3 |
(2S,4R)- 4 -甲基谷氨酸
|
(2S,4R)-4-甲基谷氨酸
|
C6H11NO4 |
161.16 | |
|
DAMGO
|
78123-71-4 |
(D-ALA2,N-ME-PHE4,GLYCINOL5)-ENKEPHALIN
|
L-酪氨酰-D-丙氨酰甘氨酰-N-(2-羟基乙基)-NALPHA-甲基-L-苯丙氨酰胺
|
C26H35N5O6 |
513.59 | |
|
4'-CHLORO-3-METHOXYCINNAMANILIDE
|
472981-92-3 |
3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺
|
N-(3-甲氧基苯基)-4-氯肉桂酰胺;3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺;SB 366791;SB366791;3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺>98%;(E)-3-(4-CHLOROPHENYL)-N-(3-METHOXYPHENYL)ACRYLAMIDE
|
C16H14ClNO2 |
287.74 | |
|
Phenethyl 3-(3,4-Dihydroxyphenyl)acrylate
|
104594-70-9 |
咖啡酸苯乙酯
|
CAPE (咖啡酸苯乙酯);咖啡酸苯乙酯;咖啡酸β-苯乙醇酯;咖啡酸苯乙酯;咖啡酸苯乙酯CAPE;咖啡酸苯乙酯,一种蛋白酪氨酸激酶和鸟氨酸脱羧酶抑制剂;咖啡酸苯乙酯标准品;CAPE、咖啡酸Β-苯乙醇酯
|
C17H16O4 |
284.31 | 627-151-0 |
|
2-(4-(1H-Tetrazol-5-yl)phenyl)-2-aminopropanoic acid
|
169209-66-9 |
(±)-Α-甲基-(4-四氮唑苯)日氨酸
|
(±)-Α-甲基-(4-四氮唑苯)日氨酸
|
C10H11N5O2 |
233.23 | |
|
UROTENSIN II (HUMAN)
|
251293-28-4 |
GLU-THR-PRO-ASP-CYS-PHE-TRP-LYS-TYR-CYS-VAL(DISULFIDE BRIDGE:CYS5-CYS1)
|
|
C64H87N13O18S2 |
1390.58 | |
|
Nitrendipine
|
39562-70-4 |
尼群地平
|
乐卡地平乙基甲酯杂质(杂质5);硝苯甲乙吡啶;2,6-二甲基-4-(3-硝基苯基)-L,4-二氢-3,5-吡啶二羧酸甲乙酯;1,4-二氢-2,6-二甲基-4-(3-硝基苯)-3,5-吡啶二羧酸乙基甲酯;乐卡地平乙基甲基酯杂质(杂质5);乐卡地平甲基乙基酯杂质;尼群地平杂质对照品;尼群地平,≥95.1%
|
C18H20N2O6 |
360.36 | 254-513-1 |
|
Camptothecine
|
7689-03-4 |
喜树碱
|
(+)-喜树碱;.0鈦鈦0¹;CAMPTOTHECIN (IRINOTECAN EP IMPURITY D);伊立替康EP杂质D;鈦²;鈦癩HENICOSA-1(21),2,4,6,8,10,15(20)-HEPTAENE-14,19-DIONE;IRINOTECAN EP IMPURITY D (CAMPTOTHECIN);喜树碱
|
C20H16N2O4 |
348.36 | 444-280-6 |
|
2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE
|
1428-67-7 |
2,3-双(4-羟苯基)丙腈
|
2,3-双(4-羟苯基)丙腈
|
C15H13NO2 |
239.27 | |
|
Flunarizine Hydrochloride
|
30484-77-6 |
盐酸氟桂利嗪
|
盐酸氟桂嗪;(E)-1-[双(4-氟苯基)甲基]-4-(3-苯基-2-丙烯基)-哌嗪二盐酸盐;氟桂利嗪-D8二盐酸盐;氟桂嗪 二盐酸盐;1-[双(4-氟苯基)甲基]-4-(3-苯基-2-丙烯基)哌嗪 二盐酸盐;盐酸氟桂利嗪对照品;盐酸氟桂利嗪;(E)-1-(双(4-氟苯基)甲基)-4-(3-苯基-3-丙烯基)-哌嗪二盐酸盐
|
C26H26F2N2·2(HCl) |
477.42 | 250-216-6 |
|
12-O-tetradecanoyl phorbol-13-acetate
|
16561-29-8 |
佛波醇12-十四酸酯13-乙酸酯
|
佛波醇12-十四酸酯13-乙酸酯;豆蔻酰佛波醇乙酯;乙酸佛波酯 PMA;乙酸佛波酯;佛波醇12-十四酸酯13-乙酸酯(佛波酯);佛波醇-12-肉豆蔻酯-13-乙酯;佛波醇12-十四酸酯13-醋酸酯(-20°C);12-O-TETRADECANOYL PHORBOL-13-ACETATE;COCARCINOGEN A1;COCARCINOGEN C3
|
C36H56O8 |
616.83 | 605-413-5 |
|
cilostazol
|
73963-72-1 |
西洛他唑
|
6-[4-(1-环己基-1H-戊四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹诺酮;西洛他唑;西斯他唑;四氮唑(西洛他唑中间体);CILOSTAZOL INTERMEDIATES;6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹诺酮;西洛他唑杂质;西洛他唑[73963-72-2]
|
C20H27N5O2 |
369.46 | 689-122-9 |
|
GBR-12935 di hydrochloride
|
67469-81-2 |
1-(2-(BENZHYDRYLOXY)ETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE.2HCL
|
GBR 12935双盐酸盐;1-[2-(二苯基甲氧基)乙基]-4-(3-苯基丙基)哌嗪二盐酸盐
|
C28H36Cl2N2O |
487.5 | |
|
Antisauvagine-30
|
220673-95-0 |
(D-PHE11,HIS12)-SAUVAGINE (11-4)
|
蛙皮降压肽抗体-30
|
C161H273N47O47S |
3651.24 | |
|
IRL-2500
|
169545-27-1 |
N-3-[1,1'-BIPHENYL]-4-YL-N-(3,5-DIMETHYLBENZOYL)-N-METHYL-D-ALANYL-L-TRYPTOPHAN
|
|
C36H35N3O4 |
573.68 | |
|
CFM-2
|
178616-26-7 |
178616-26-7
|
|
C17H17N3O3 |
311.34 | |
|
Isradipine
|
75695-93-1 |
伊拉地平
|
4-(4-苯并呋咱基)-2,6-二甲基-1,4-二氢-3,5-吡啶二羧酸甲酯1-甲基乙酯;导脉顺;地拉平;伊拉地平;伊拉地平溶液,100PPM;PN 200-111;DYNACIRC;LOMIR;PRESCAL;DYNACIRC CR;伊沙地平
|
C19H21N3O5 |
371.39 | 630-420-5 |
|
(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE
|
85416-75-7 |
(4R)-4-[3-(环戊氧基)-4-甲氧基苯基]吡咯-2-酮
|
(R)-ROLIPRAM;(-)-ROLIPRAM;CS-1181;(4R)-4-[3-(环戊氧基)-4-甲氧基苯基]吡咯-2-酮;(R)-(-)-咯利普兰
|
C16H21NO3 |
275.34 | |
|
esatenolol
|
93379-54-5 |
(S)-(-)-阿替洛尔
|
(S)-(-)-阿替洛尔;()-4-[2-羟基-3-[(2-甲乙基)氨基]丙氧基]苯乙酰胺;阿替洛尔S-异构体
|
C14H22N2O3 |
266.34 | |
|
5-FLUORO-2-METHOXY-[1-[2-[(METHYLSULFONYL)AMINO]ETHYL]-4-PIPERIDINYL]-1H-INDOLE-3-METHYLCARBOXYLATE SULFAMATE
|
144625-67-2 |
5 - 氟2 - 甲氧基- 1H -吲哚3 - 羧基酸-[1 - [2 - [(甲磺酰基)氨基]乙基] -4 - 哌啶基]甲酯
|
5-氟2-甲氧基-1H-吲哚3-羧基酸-[1-[2-[(甲磺酰基)氨基]乙基]-4-哌啶基]甲酯;5-氟-2-甲氧基-1H-吲哚-3-羧酸 [1-[2-[(甲基磺酰基)氨基]乙基]-4-哌啶基]甲基酯
|
C19H29FN4O8S2 |
524.58 |
药智官方微信
药智官方微博
